Rapid Downregulation of Cyclin D1 Induced by Geranylgeranoic Acid in Human Hepatoma Cells

REFERENCES

• Freemantle , S J , Guo , Y and Dmitrovsky , E . 2009 . Retinoid chemoprevention trials: cyclin D1 in the crosshairs . Cancer Prev Res (Phila Pa) , 2 : 3 – 6 .
   PubMed Web of Science ®Google Scholar
• Kim , J K and Diehl , J A . 2009 . Nuclear cyclin D1: an oncogenic driver in human cancer . J Cell Physiol , 220 : 292 – 296 .
   PubMed Web of Science ®Google Scholar
• Piechocki , M P , Yoo , G H , Dibbley , S K and Lonardo , F . 2007 . Breast cancer expressing the activated her2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the her2/neu . Cancer Res , 67 : 6825 – 6843 .
   PubMed Web of Science ®Google Scholar
• Papadimitrakopoulou , V , Izzo , J G , Liu , D D , Meyers , J Ceron , TL . 2009 . Cyclin D1 and cancer development in laryngeal premalignancy patients . Cancer Prev Res (Phila Pa) , 2 : 14 – 21 .
   Web of Science ®Google Scholar
• Izzo , J G , Wu , T T , Wu , X , Ensor , J Luthra , R . 2007 . Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma . J Clin Oncol , 25 : 698 – 707 .
   PubMed Web of Science ®Google Scholar
• Lippman , S M , Lee , J S , Lotan , R , Hittelman , W Wargovich , M J . 1990 . Biomarkers as intermediate end points in chemoprevention trials . J Natl Cancer Inst , 82 : 555 – 560 .
   PubMed Web of Science ®Google Scholar
• Papadimitrakopoulou , V A , Lee , J J , William , W N Jr. , Martin , JW Thomas , M . 2009 . Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy . J Clin Oncol , 27 : 599 – 604 .
   PubMed Web of Science ®Google Scholar
• Langenfeld , J , Kiyokawa , H , Sekula , D , Boyle , J and Dmitrovsky , E . 1997 . Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism . Proc Natl Acad Sci U S A , 94 : 12070 – 12074 .
   PubMed Web of Science ®Google Scholar
• Dragnev , K H , Feng , Q , Ma , Y , Shah , SJ Black , C . 2007 . Uncovering novel targets for cancer chemoprevention . Recent Results Cancer Res , 174 : 235 – 243 .
   Google Scholar
• Muto , Y , Moriwaki , H and Saito , A . 1999 . Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma . N Engl J Med , 340 : 1046 – 1047 .
   PubMed Web of Science ®Google Scholar
• Muto , Y , Moriwaki , H , Ninomiya , M , Adachi , S Saito , A . 1996 . Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group . N Engl J Med , 334 : 1561 – 1567 .
   PubMed Web of Science ®Google Scholar
• Larson , R S and Tallman , M S . 2003 . Retinoic acid syndrome: Manifestations, pathogenesis, and treatment . Best Pract Res Clin Haematol , 16 : 453 – 461 .
   PubMed Web of Science ®Google Scholar
• Ortega , J J , Madero , L , Martin , G , Verdeguer , A García , P . 2005 . Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the pethema group . J Clin Oncol , 23 : 7632 – 7640 .
   PubMed Web of Science ®Google Scholar
• Shimizu , M , Suzui , M , Deguchi , A , Lim , JT Xiao , D . 2004 . Synergistic effects of acyclic retinoid and osi-461 on growth inhibition and gene expression in human hepatoma cells . Clin Cancer Res , 10 : 6710 – 6721 .
   Web of Science ®Google Scholar
• Shimizu , M , Suzui , M , Deguchi , A , Lim , J T and Weinstein , I B . 2004 . Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells . Clin Cancer Res , 10 : 1130 – 1140 .
   Web of Science ®Google Scholar
• Suzui , M , Sunagawa , N , Chiba , I , Moriwaki , H and Yoshimi , N . 2006 . Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells . Int J Oncol , 28 : 1193 – 1199 .
   Web of Science ®Google Scholar
• Shidoji , Y and Ogawa , H . 2004 . Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbs . J Lipid Res , 45 : 1092 – 1103 .
   PubMed Web of Science ®Google Scholar
• Moriwaki , H , Muto , Y , Ninomiya , M , Kawai , K Suzuki , Y . 1988 . Inhibitory effects of synthetic acidic retinoid and polyprenoic acid on the development of hepatoma in rats induced by 3′-methyl-n, n-dimethyl-4-aminoazobenzene . Gastroenterol Jpn , 23 : 546 – 552 .
   Google Scholar
• Muto , Y , Moriwaki , H and Shiratori , Y . 1998 . Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma . Digestion , 59 ( Suppl 2 ) : 89 – 91 .
   Web of Science ®Google Scholar
• Muto , Y , Moriwaki , H and Omori , M . 1981 . In vitro binding affinity of novel synthetic polyprenoids (polyprenoic acids) to cellular retinoid-binding proteins . Gann , 72 : 974 – 977 .
   PubMedGoogle Scholar
• Yamada , Y , Shidoji , Y , Fukutomi , Y , Ishikawa , T Kaneko , T . 1994 . Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines . Mol Carcinog , 10 : 151 – 158 .
   Web of Science ®Google Scholar
• Shidoji , Y , Nakamura , N , Moriwaki , H and Muto , Y . 1997 . Rapid loss in the mitochondrial membrane potential during geranylgeranoic acid-induced apoptosis . Biochem Biophys Res Commun , 230 : 58 – 63 .
   Web of Science ®Google Scholar
• Freemantle , S J , Liu , X , Feng , Q , Galimberti , F Blumen , S . 2007 . Cyclin degradation for cancer therapy and chemoprevention . J Cell Biochem , 102 : 869 – 877 .
   Web of Science ®Google Scholar
• Feng , Q , Sekula , D , Muller , R , Freemantle , S J and Dmitrovsky , E . 2007 . Uncovering residues that regulate cyclin D1 proteasomal degradation . Oncogene , 26 : 5098 – 5106 .
   Web of Science ®Google Scholar
• Nakamura , N , Shidoji , Y , Moriwaki , H and Muto , Y . 1996 . Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via downregulation of transforming growth factor-alpha . Biochem Biophys Res Commun , 219 : 100 – 104 .
   PubMed Web of Science ®Google Scholar
• Shidoji , Y , Okamoto , K , Muto , Y , Komura , S Ohishi , N . 2006 . Prevention of geranylgeranoic acid-induced apoptosis by phospholipid hydroperoxide glutathione peroxidase gene . J Cell Biochem , 97 : 178 – 187 .
   Web of Science ®Google Scholar
• Kodaira , Y , Kusumoto , T , Takahashi , T , Matsumura , Y Miyagi , Y . 2007 . Formation of lipid droplets induced by 2,3-dihydrogeranylgeranoic acid distinct from geranylgeranoic acid . Acta Biochim Pol , 54 : 777 – 782 .
   Web of Science ®Google Scholar
• Alao , J P . 2007 . The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention . Mol Cancer , 6 : 24
   PubMed Web of Science ®Google Scholar
• Zhang , Y J , Chen , S Y , Chen , C J and Santella , R M . 2002 . Polymorphisms in cyclin D1 gene and hepatocellular carcinoma . Mol Carcinog , 33 : 125 – 129 .
   PubMed Web of Science ®Google Scholar
• Santra , M K , Wajapeyee , N and Green , M R . 2009 . F-box protein FBXO31 mediates cyclin D1 degradation to induce g1 arrest after DNA damage . Nature , 459 : 722 – 725 .
   PubMed Web of Science ®Google Scholar
• Takahashi-Yanaga , F and Sasaguri , T . 2008 . Gsk-3beta regulates cyclin D1 expression: a new target for chemotherapy . Cell Signal , 20 : 581 – 589 .
   PubMed Web of Science ®Google Scholar
• Scita , G , Darwiche , N , Greenwald , E , Rosenberg , M Politi , K . 1996 . Retinoic acid downregulation of fibronectin and retinoic acid receptor alpha proteins in NIH-3T3 cells: blocks of this response by ras transformation . J Biol Chem , 271 : 6502 – 6508 .
   Web of Science ®Google Scholar
• Newman , R M , Mobascher , A , Mangold , U , Koike , C Diah , S . 2004 . Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression . J Biol Chem , 279 : 41504 – 41511 .
   PubMed Web of Science ®Google Scholar
• Araki , H , Shidoji , Y , Yamada , Y , Moriwaki , H and Muto , Y . 1995 . Retinoid agonist activities of synthetic geranylgeranoic acid derivatives . Biochem Biophys Res Commun , 209 : 66 – 72 .
   Web of Science ®Google Scholar
• Shimizu , M , Sakai , H , Shirakami , Y , Iwasa , J Yasuda , Y . 2011 . Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice . Cancer Prev Res (Phila Pa) , 4 : 128 – 136 .
   PubMed Web of Science ®Google Scholar
• Yu , Z , Willmarth , N E , Zhou , J , Katiyar , S Wang , M . 2010 . MicroRNA17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling . Proc Natl Acad Sci USA , 107 : 8231 – 8236 .
   PubMed Web of Science ®Google Scholar
• Xia , W , Li , J , Chen , L , Huang , B Li , S . 2010 . MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells . Mol Cell Biochem , 344 : 261 – 266 .
   Web of Science ®Google Scholar
• Qin , X , Wang , X , Wang , Y , Tang , Z Cui , Q . 2010 . MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells . Proc Natl Acad Sci U S A , 107 : 3240 – 3244 .
   PubMed Web of Science ®Google Scholar
• Chen , J , Feilotter , H E , Pare , G C , Zhang , X Pemberton , JG . 2010 . MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma . Am J Pathol , 176 : 2520 – 2529 .
   PubMed Web of Science ®Google Scholar
• Jiang , Q , Feng , M G and Mo , Y Y . 2009 . Systematic validation of predicted micrornas for cyclin D1 . BMC Cancer , 9 : 194
   PubMed Web of Science ®Google Scholar
• Sun , F , Fu , H , Liu , Q , Tie , Y Zhu , J . 2008 . Downregulation of CCND1 and CDK6 by mir-34a induces cell cycle arrest . FEBS Lett , 582 : 1564 – 1568 .
   PubMed Web of Science ®Google Scholar
• Davies , B P and Arenz , C . 2008 . A fluorescence probe for assaying micro RNA maturation . Bioorg Med Chem , 16 : 49 – 55 .
   PubMed Web of Science ®Google Scholar
• Fan , S , Li , Y , Yue , P , Khuri , F R and Sun , S Y . 2010 . The eIF4e/eIF4G interaction inhibitor 4eGI-1 augments trail-mediated apoptosis through c-FLIP downregulation and DR5 induction independent of inhibition of CAP-dependent protein translation . Neoplasia , 12 : 346 – 356 .
   Web of Science ®Google Scholar
• Jiao , W , Lin , H M , Datta , J , Braunschweig , T Chung , JY . 2008 . Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation . Oncogene , 27 : 3156 – 3164 .
   PubMed Web of Science ®Google Scholar
• Nishida , N , Fukuda , Y , Komeda , T , Kita , R Sando , T . 1994 . Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma . Cancer Res , 54 : 3107 – 3110 .
   PubMed Web of Science ®Google Scholar
• Huang , H L , Zheng , W L , Zhao , R , Zhang , B and Ma , W L . 2010 . FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma . Oncol Rep , 24 : 715 – 720 .
   Web of Science ®Google Scholar
• Deane , N G , Parker , M A , Aramandla , R , Diehl , L Lee , WJ . 2001 . Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice . Cancer Res , 61 : 5389 – 5395 .
   PubMed Web of Science ®Google Scholar
• Arber , N , Doki , Y , Han , E K , Sgambato , A Zhou , P . 1997 . Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells . Cancer Res , 57 : 1569 – 1574 .
   PubMed Web of Science ®Google Scholar
• Weinstein , I B , Begemann , M , Zhou , P , Han , EK Sgambato , A . 1997 . Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy . Clin Cancer Res , 3 : 2696 – 2702 .
   PubMed Web of Science ®Google Scholar